Perigon Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Perigon Wealth Management, LLC

$3.67 Billion
Q3 2024

A detailed history of Perigon Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 38,041 shares of GILD stock, worth $3.42 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

38,041

Previous 39,786 4.39%

Holding current value

$3.42 Million

Previous $2.73 Million 16.82%

% of portfolio

0.09%

Previous 0.08%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$66.59 - $83.99 $116,199 - $146,562	-1,745 Reduced 4.39%	38,041 $3.19 Million
Q2 2024 Aug 02, 2024	SELL	$63.15 - $72.88 $50,772 - $58,595	-804 Reduced 1.98%	39,786 $2.73 Million
Q1 2024 Apr 29, 2024	SELL	$71.58 - $87.29 $5,583 - $6,808	-78 Reduced 0.19%	40,590 $2.97 Million
Q4 2023 Jan 29, 2024	BUY	$73.27 - $83.09 $280,770 - $318,400	3,832 Added 10.4%	40,668 $3.29 Million
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $3,401 - $3,710	46 Added 0.13%	36,836 $2.76 Million
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $115,155 - $131,350	1,515 Added 4.29%	36,790 $2.84 Million
Q1 2023 May 03, 2023	BUY	$77.31 - $88.08 $173,715 - $197,915	2,247 Added 6.8%	35,275 $2.93 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $257,443 - $369,600	4,131 Added 14.3%	33,028 $2.84 Million
Q3 2022 Dec 13, 2022	BUY	$59.54 - $68.01 $116,698 - $133,299	1,960 Added 7.28%	28,897 $1.78 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $1,500 - $1,690	26 Added 0.1%	26,937 $1.67 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $1.37 Million - $1.72 Million	-23,644 Reduced 46.77%	26,911 $1.6 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $15,441 - $17,526	238 Added 0.47%	50,555 $3.67 Million
Q3 2021 Nov 01, 2021	BUY	$67.69 - $73.03 $3.41 Million - $3.67 Million	50,317 New	50,317 $3.52 Million
Q3 2021 Oct 25, 2021	SELL	$67.69 - $73.03 $3.39 Million - $3.65 Million	-50,039 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $373,965 - $408,610	-5,892 Reduced 10.53%	50,039 $3.45 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $13,860 - $15,814	-231 Reduced 0.41%	55,931 $3.62 Million
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $192,666 - $219,534	-3,401 Reduced 5.71%	56,162 $3.27 Million
Q3 2020 Nov 03, 2020	BUY	$62.1 - $78.08 $35,645 - $44,817	574 Added 0.97%	59,563 $3.76 Million
Q2 2020 Jul 29, 2020	BUY	$72.34 - $84.0 $169,347 - $196,644	2,341 Added 4.13%	58,989 $4.54 Million
Q1 2020 Apr 17, 2020	BUY	$62.63 - $80.22 $386,614 - $495,198	6,173 Added 12.23%	56,648 $4.16 Million
Q4 2019 Jan 13, 2020	BUY	$61.62 - $67.78 $142,465 - $156,707	2,312 Added 4.8%	50,475 $3.31 Million
Q3 2019 Oct 25, 2019	SELL	$62.51 - $69.0 $198,281 - $218,868	-3,172 Reduced 6.18%	48,163 $3.15 Million
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $10,208 - $11,447	165 Added 0.32%	51,335 $3.47 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $47,835 - $53,588	-765 Reduced 1.47%	51,170 $3.28 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $183,133 - $238,975	-3,025 Reduced 5.5%	51,935 $3.58 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $18,532 - $20,519	260 Added 0.48%	54,960 $4.24 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $315,965 - $368,561	4,870 Added 9.77%	54,700 $3.88 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $12,674 - $15,451	-174 Reduced 0.35%	49,830 $3.76 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $44,468 - $52,200	-625 Reduced 1.23%	50,004 $3.58 Million
Q3 2017 Dec 05, 2017	SELL	$72.11 - $85.47 $1.43 Million - $1.7 Million	-19,869 Reduced 28.18%	50,629 $4.1 Million
Q2 2017 Sep 12, 2017	BUY	N/A	70,498 New	70,498 $4.99 Million
Q3 2011 Nov 14, 2022	BUY	N/A	1,960	28,897 $1.78 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.

Account

Perigon Wealth Management, LLC Gilead Sciences, Inc. Transaction History